Universal Health Services Reports Q2 2026 Earnings and Revises Full-Year Forecast

Universal Health Services Reports Q2 2026 Earnings and Revises Full-Year Forecast

Universal Health Services, Inc. (UHS) has released its financial results for the second quarter of 2026, reporting a net income of $358.4 million, or $5.98 per diluted share. This marks a slight increase from the $353.2 million, or $5.43 per diluted share, reported in the same quarter of 2025. Net revenues rose by 8.3% to $4.638 billion, up from $4.284 billion in the corresponding period last year.

Key Financial Highlights

• Net Income: $358.4 million, or $5.98 per diluted share.
• Net Revenues: $4.638 billion, an 8.3% increase from Q2 2025.
• Adjusted Net Income: $371.4 million, or $5.88 per diluted share.

These figures include a favorable net pre-tax impact of approximately $72 million, primarily due to the Florida Medicaid managed care directed payment program and an increase in the reserve for self-insured professional and general liability claims.

Analyst Perspectives

Analyst opinions on UHS’s performance have been mixed. Cantor Fitzgerald reiterated a “Neutral” rating, citing challenges in meeting consensus estimates for inpatient volume growth. Conversely, UBS maintained a “Buy” rating with a price target of $310, highlighting the company’s undervaluation and potential for earnings growth.

Market Reaction

Following the earnings announcement, UHS’s stock price experienced volatility. As of July 28, 2026, the stock closed at $166.22, reflecting an 11.15% increase from the previous close. This surge indicates investor optimism despite the earnings miss.

Conclusion

While UHS’s Q2 2026 earnings fell short of analyst expectations, the company’s revenue growth and revised full-year forecast suggest a positive outlook. Investors should monitor upcoming quarters to assess the company’s ability to meet its projected targets.